FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3442104013 1 (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core
    3442105014 1 en Synonym Active Case insensitive SNOMED CT core
    64719019 One en Synonym Active Case insensitive SNOMED CT core
    771016011 One (qualifier value) en Fully specified name Inactive Initial character case insensitive SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Canakinumab 150 mg lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Canakinumab 150 mg lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Canakinumab only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Lurbinectedin only product Count of base of active ingredient False 1 Inferred relationship Some
    Lurbinectedin 4 mg lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Lurbinectedin 4 mg lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Lurbinectedin only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Metoprolol tartrate (as metoprolol succinate) 200 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Metoprolol tartrate (as metoprolol succinate) 200 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Selinexor 20 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Selinexor 20 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Burosumab 10 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Burosumab 10 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Burosumab 30 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Burosumab 30 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Burosumab 20 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Burosumab 20 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Luspatercept 25 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Luspatercept 25 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Luspatercept 75 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Luspatercept 75 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen only vaccine product Count of active ingredient False 1 Inferred relationship Some
    Neisseria meningitidis serogroup C only vaccine product Count of active ingredient False 1 Inferred relationship Some
    Polyestradiol only product Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir only product Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir 600 mg prolonged-release oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Fostemsavir 600 mg prolonged-release oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mebendazole 500 mg chewable tablet Count of base of active ingredient False 1 Inferred relationship Some
    Mebendazole 500 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pyrantel (as pyrantel pamoate) 50 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triclabendazole 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Triclabendazole 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benznidazole 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Benznidazole 100 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benznidazole 12.5 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Benznidazole 12.5 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Clindamycin (as clindamycin palmitate hydrochloride) 15 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Clindamycin (as clindamycin palmitate hydrochloride) 15 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Abiraterone acetate 500 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Abiraterone acetate 500 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Adalimumab 100 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Adalimumab 100 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Triclabendazole 250 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Triclabendazole 250 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Benzylpenicillin (as benzylpenicillin potassium) 5 million unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cedazuridine 100 mg and decitabine 35 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Miltefosine 50 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Miltefosine 50 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Miltefosine 10 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Miltefosine 10 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amphotericin B liposome 50 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amphotericin B liposome 50 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Ombitasvir 12.5 mg and paritaprevir 75 mg and ritonavir 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Ledipasvir 90 mg and sofosbuvir 400 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ledipasvir 90 mg and sofosbuvir 400 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 2
    Sofosbuvir 400 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Sofosbuvir 400 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Brexucabtagene autoleucel only product Count of base of active ingredient False 1 Inferred relationship Some
    Brexucabtagene autoleucel only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Afatinib (as afatinib dimaleate) 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Afatinib (as afatinib dimaleate) 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Agomelatine 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Agomelatine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Phenazone 50 mg/mL ear drops solution Count of base of active ingredient False 1 Inferred relationship Some
    Phenazone 50 mg/mL ear drops solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Bisacodyl 2 mg/mL rectal suspension Count of base of active ingredient False 1 Inferred relationship Some
    Bisacodyl 2 mg/mL rectal suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Agomelatine only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Phenazone only product in otic dose form Count of base of active ingredient False 1 Inferred relationship Some
    Cinnarizine 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Cinnarizine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Capecitabine 300 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Capecitabine 300 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 75 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 75 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 25 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 10 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Brivaracetam 10 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Brivaracetam 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 108 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start